PHEBRA WORLDWIDE
HEALTHCARE PROFESSIONALS PHEBWEB ONLINE ORDERING
PHEBRA WORLDWIDE
  • About
  • Products
  • Media & Press
  • Careers
  • Contact
  • Products
  • Unapproved Products

Products

  • 1
  • 2
  • 3
  • PTU™ Tablets (propylthiouracil)
  • Quinine Dihydrochloride 6% Solution for Injection
  • Retinofluor® (10%) Injection (fluorescein sodium)
  • Sodium Bicarbonate (8.4%) Injection (10 mL)
  • Sodium Bicarbonate (8.4%) Injection (100 mL)
  • Sodium Chloride (0.9%) Injection
  • Sodium Chloride (23.4%) Concentrated Injection
  • Sucrose Oral Solution 24%
  • Sulthiame Tablets (Ospolot®) (200 mg)
  • Sulthiame Tablets (Ospolot®) (50 mg)
  • Syntometrine® Injection (ergometrine and oxytocin)
  • Tadim® Powder for Nebuliser Solution (colistimethate sodium)
  • Tobra-day® Injection (tobramycin)
  • Tobramycin Injection (Tobra-day®)
  • Water for Injection
  • Zinc Chloride Concentrated Injection
  • 1
  • 2
  • 3
Phebra footer logo

Phebra Customer Service

  • 1800 720 020 (AUS)
  • +61 (0) 2 9420 9199
Head Office & Manufacturing Sydney
19 Orion Road,
Lane Cove West,
NSW 2066
Australia
Sales & Marketing Melbourne
8/875 Glen Huntly Road,
Caulfield.
VIC 3162
Australia
Menu
  • Website Terms & Conditions
  • Terms & Conditions of Sale
  • Website Privacy Statement
  • Contact Us
Phebra Pty Ltd acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia and their continuing connection to lands, waters and communities. We pay our respects to Aboriginal and Torres Strait Islander cultures; and to all Elders both past and present.

© Phebra Pty Ltd 2024, All rights reserved. Phebra and the Phi symbol are registered trademarks of Phebra Pty Ltd. ACN: 059 357 890 ABN: 99 059 357 890